Wire
05:52ZINDIANEXPRKeralite vlogger claims she escaped arrest threat in Afghanistan05:52ZTASNIMNEWSIran authorizes new luxury brand for overseas Iranians to import vehicles05:51ZGAZAALANPAPalestinian man, 54, dies after being shot by Israeli forces during raid in Umm al-Sharayet area05:50ZPRESSTVIRGC shoots down MQ-1 drone over western Strait05:48ZWORLD NEWSAustralian politics live: Fugitive developer Jean Nassif tells Icac ‘I’m not corrupt’ and ‘you want the count…05:47ZHINDUSTANTGurugram Man Charged in Bike Crash That Hit Woman Biker on Golf Course Road05:45ZENGLISHABUTrump says Russia, Ukraine agree not to target each other's energy facilities05:45ZSPRINTERPRIn Saudi Arabia, in several areas, rocket attack alerts were activated overnight due to threats of Houthi air…
  • S&P 500 ETF 0.45%
  • Nasdaq 0.56%
  • Nasdaq 100 0.82%
  • Dow ETF 0.25%
Terminal ↗
← The MonexusScience

Gut-first drug reverses severe fatty liver in mice, putting microbiome–metabolism axis back at centre of therapeutics

An experimental compound repaired the gut lining, blocked toxin traffic to the liver, and reversed severe fatty liver disease in animal studies, a reminder that the next wave of metabolic drugs may arrive via the intestine, not the hepatocyte.

People hold up smartphones to photograph a partially eclipsed sun setting over a city skyline.
People hold up smartphones to photograph a partially eclipsed sun setting over a city skyline. @NEW SCIENTIST · Telegram

Wire provenance

This editorial synthesis draws on the following public wire/social posts:

  • https://t.me/themonexus/1
  • https://en.wikipedia.org/wiki/Metabolic_dysfunction-associated_steatotic_liver_disease
  • https://en.wikipedia.org/wiki/Resmetirom
  • https://en.wikipedia.org/wiki/Intestinal_permeability

At the source.

Open the posts cited in this article.

Telegram postOpen original ↗

Live content may have changed since this article was published. Loading it contacts Telegram.

Intelligence ThreadFollow on terminal ↗
© 2026 Monexus Media · AI-native reporting from public-source material
The Monexus

Read with context.

Using this article and its related event records

Find the evidence behind a claim, inspect a dated position, or pick up the thread.

Source lookup is available to everyone. Members can request an AI explanation grounded in the retrieved material.

Browse event files →
Gut-first drug reverses severe fatty liver in mice, putting microbiome–metabolism axis back at centre of therapeutics - The Monexus